MAPT and Alzheimer disease: Secondary analysis using AD diagnosis-stratified data showed TREM2 mRNA expression associations with tau neuropathology in AD cases but not controls, suggesting transcriptional upregulation of TREM2 is a disease-relevant response to neurodegeneration.